Trial reportThe international journal of medical robotics + computer assisted surgery : MRCAS2026
Efficacy and Safety Analysis of Single-Port Robotic Assisted Cholecystectomy Using a Novel Surgical Platform: A Bicentre, Single-Arm, Prospective Phase II Clinical Study.
Trial report in The international journal of medical robotics + computer assisted surgery : MRCAS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy and Safety Analysis of Single-Port Robotic Assisted Cholecystectomy Using a Novel Surgical Platform: A Bicentre, Single-Arm, Prospective Phase II Clinical Study.The international journal of medical robotics + computer assisted surgery : MRCAS · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundSingle-port robotic cholecystectomy offers minimally invasive benefits. This trial evaluated the feasibility and safety of a novel system, MicroPort SA-1000.
methodsIn this dual centre, single-arm, prospective study, eligible patients underwent single-port robot-assisted cholecystectomy with MicroPort SA-1000. The primary endpoint was the completion rate, while secondary endpoints included estimated blood loss, operating time, hospital length of stay and complications.
resultsFrom June 2023 to December 2023, a total of 44 patients from two centres were enrolled, and all patients underwent single-port robot-assisted cholecystectomy without conversion. The median EBL was 10 mL (range 5-200 mL). The total operative time was 88.43 ± 25.87 minutes. The median LOS was 2.5 days (range 1-7 days). No serious surgery-related adverse events were observed.
conclusionsThe novel single-port robot demonstrated feasibility and safety in cholecystectomy with effective triangulation, controlled operative time and reduced trauma. Larger studies are needed to validate its performance across different surgical fields.
trial registrationThis study was registered at https://www.chictr.org.cn/showproj.html?proj=258677 (ChiCTR2500107401).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.